Brief: Netscientific Says PDS Biotechnology Announces Achievement Of Efficacy Threshold in Stage 2 of VERSATILE-002 Trial Evaluating PDS0101 and Keytruda

EMV Capital

14/06/2023 18:33

June 14 (Reuters) - Netscientific PLC  NSCI.L :
    * NETSCIENTIFIC PLC  - PDS ANNOUNCES ACHIEVEMENT OF EFFICACY
THRESHOLD
    * NETSCIENTIFIC - 14 PATIENTS IN IMMUNE CHECKPOINT INHIBITOR
NAÏVE
ARM OF VERSATILE-002 SAW COMPLETE RESPONSE OR PARTIAL RESPONSE
ON 2 CONSECUTIVE SCANS

Source text for Eikon:  urn:newsml:reuters.com:*:nRSN7448Ca
Further company coverage:  NSCI.L 

 ((Reuters.Briefs@thomsonreuters.com;))